within Pharmacolibrary.Drugs.ATC.R;

model R05CA08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.4,
    Cl             = 3.3333333333333335e-05,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.03,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0005,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>R05CA08</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Creosote is a complex mixture of phenolic compounds derived from the distillation of tar, primarily used historically as a disinfectant, expectorant, and externally as an antiseptic. It was formerly indicated for cough and respiratory tract diseases but is no longer approved as a therapeutic drug due to its toxicity and carcinogenic potential.</p><h4>Pharmacokinetics</h4><p>No published human pharmacokinetic studies or clinical PK models specifically for creosote are available. Estimated parameters provided below refer to a hypothetical adult oral administration in the absence of referenced data.</p><h4>References</h4><ol><li><p>Kuge, T, et al., &amp; Willett, MS (2003). Wood creosote, the principal active ingredient of seirogan, an herbal antidiarrheal medicine: a single-dose, dose-escalation safety and pharmacokinetic study. <i>Pharmacotherapy</i> 23(11) 1391–1400. DOI:<a href=&quot;https://doi.org/10.1592/phco.23.14.1391.31940&quot;>10.1592/phco.23.14.1391.31940</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/14620385/&quot;>https://pubmed.ncbi.nlm.nih.gov/14620385</a></p></li><li><p>Roberts, SM, et al., &amp; Stuchal, LD (2019). Bioaccessibility of polychlorinated dioxins and furans in soil from a Superfund site. <i>Chemosphere</i> 214 418–423. DOI:<a href=&quot;https://doi.org/10.1016/j.chemosphere.2018.09.044&quot;>10.1016/j.chemosphere.2018.09.044</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/30268897/&quot;>https://pubmed.ncbi.nlm.nih.gov/30268897</a></p></li><li><p>Ogata, N, &amp; Shibata, T (2000). Binding of alkyl- and alkoxy-substituted simple phenolic compounds to human serum proteins. <i>Research communications in molecular pathology and pharmacology</i> 107(1-2) 167–173. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/11334365/&quot;>https://pubmed.ncbi.nlm.nih.gov/11334365</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end R05CA08;
